Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr704 Inhibitors

Olr704 inhibitors represent a specialized category of chemical compounds that interact specifically with the Olr704 receptor, a member of the olfactory receptor family. These receptors are G protein-coupled receptors (GPCRs) primarily involved in the detection of odorants, playing a critical role in the olfactory system. Olr704, like other olfactory receptors, spans the cellular membrane and undergoes conformational changes upon binding with specific ligands. The inhibition of Olr704 is a fascinating area of study because it provides insights into the molecular mechanisms underlying olfaction, a complex sensory process. Researchers are particularly interested in understanding how these inhibitors bind to the receptor, the structural features that facilitate their selective interaction, and the resultant biochemical cascades that are modulated upon inhibition.

Investigating Olr704 inhibitors involves a multidisciplinary approach that encompasses organic chemistry, structural biology, and biophysics. Chemists synthesize a variety of inhibitor molecules, often employing structure-activity relationship (SAR) studies to refine their efficacy and selectivity. Structural biologists utilize techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy to elucidate the three-dimensional structures of the receptor-inhibitor complexes. Furthermore, computational modeling and molecular dynamics simulations are employed to predict binding affinities and identify key interaction sites. These studies contribute significantly to the broader understanding of GPCR functionality and olfactory signal transduction. By dissecting the interactions at the atomic level, scientists can map out the intricate network of forces that govern inhibitor binding and receptor activity, thus advancing the fundamental knowledge of sensory perception and molecular signaling.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$50.00
$374.00
$2071.00
18
(1)

Modulates immune response and inhibits angiogenesis, potentially affecting proteins in these pathways.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Inhibits EGFR tyrosine kinase, potentially affecting proteins in the EGFR signaling pathway.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Dihydrofolate reductase inhibitor, potentially disrupting DNA synthesis and affecting cell replication proteins.

Pomalidomide

19171-19-8sc-364593
sc-364593A
sc-364593B
sc-364593C
sc-364593D
sc-364593E
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$100.00
$143.00
$312.00
$468.00
$1248.00
$1997.00
1
(1)

Immunomodulatory drug, potentially influencing proteins in immune response and angiogenesis.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor, potentially affecting protein degradation and cell cycle regulation.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Inhibits multiple kinases, potentially disrupting proteins in cell signaling and growth pathways.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

Inhibits cyclin-dependent kinases 4 and 6, potentially affecting cell cycle-related proteins.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

Proteasome inhibitor, potentially impacting protein degradation and cell cycle regulation.

Ribociclib

1211441-98-3sc-507367
10 mg
$450.00
(0)

Cyclin-dependent kinase 4/6 inhibitor, potentially affecting proteins involved in cell cycle regulation.

XL-184 free base

849217-68-1sc-364657
sc-364657A
5 mg
10 mg
$94.00
$208.00
1
(1)

Inhibits MET, VEGFR, and RET, potentially disrupting multiple signaling pathways.